Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma
W P Vaughan, E Kris, J Vose, et al.
Cancer Treatment Reports
|
November 1, 1981
Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts
W P Vaughan, A W Kimball, J E Karp, et al.
Medical and Pediatric Oncology
|
January 1, 1979
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breast
W P Vaughan, P M Wilcox, P O Alderson, et al.
Journal of Chromatography
|
September 8, 1993
Improved high-performance liquid chromatographic analysis of intracellular deoxyribonucleoside triphosphate levels
R A Rimerman, G D Prorok, K L Cordel, et al.
American Journal of Hematology
|
December 1, 1983
Postleukemic dysmyelopoiesis
K Foucar, W P Vaughan, J O Armitage, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Population pharmacokinetics of hydroxyurea in cancer patients
W G Tracewell, D L Trump, W P Vaughan, et al.
Bone Marrow Transplantation
|
August 1, 1987
Acute renal failure associated with autologous bone marrow transplantation
D M Smith, D D Weisenburger, P Bierman, et al.
Seminars in Oncology
|
June 1, 1992
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent
W P Vaughan, P J Bierman, E C Reed, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
January 1, 1987
The effect of the route of nutrient delivery on gut structure and diamine oxidase levels
J S Thompson, W P Vaughan, C F Forst, et al.
Blood
|
May 23, 2001
Fatal sickle cell crisis after granulocyte colony-stimulating factor administration
B K Adler, D E Salzman, M H Carabasi, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma
W P Vaughan, E Kris, J Vose, et al.
Cancer Treatment Reports
|
November 1, 1981
Factors affecting survival of patients with acute myelocytic leukemia presenting with high wbc counts
W P Vaughan, A W Kimball, J E Karp, et al.
Medical and Pediatric Oncology
|
January 1, 1979
Hepatic toxicity of adjuvant chemotherapy for carcinoma of the breast
W P Vaughan, P M Wilcox, P O Alderson, et al.
Journal of Chromatography
|
September 8, 1993
Improved high-performance liquid chromatographic analysis of intracellular deoxyribonucleoside triphosphate levels
R A Rimerman, G D Prorok, K L Cordel, et al.
American Journal of Hematology
|
December 1, 1983
Postleukemic dysmyelopoiesis
K Foucar, W P Vaughan, J O Armitage, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Population pharmacokinetics of hydroxyurea in cancer patients
W G Tracewell, D L Trump, W P Vaughan, et al.
Bone Marrow Transplantation
|
August 1, 1987
Acute renal failure associated with autologous bone marrow transplantation
D M Smith, D D Weisenburger, P Bierman, et al.
Seminars in Oncology
|
June 1, 1992
High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent
W P Vaughan, P J Bierman, E C Reed, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
January 1, 1987
The effect of the route of nutrient delivery on gut structure and diamine oxidase levels
J S Thompson, W P Vaughan, C F Forst, et al.
Blood
|
May 23, 2001
Fatal sickle cell crisis after granulocyte colony-stimulating factor administration
B K Adler, D E Salzman, M H Carabasi, et al.
Page
of 9